Active breathing control (ABC) for Hodgkin's disease: reduction in normal tissue irradiation with deep inspiration and implications for treatment.
暂无分享,去创建一个
D A Jaffray | M B Sharpe | J W Wong | J. Wong | A. Martinez | V. Kini | D. Jaffray | Alvaro Martinez | M. Sharpe | J. Stromberg | L. Kim | A A Martinez | J S Stromberg | V R Kini | L H Kim
[1] L. Boersma,et al. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Hancock,et al. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. , 1996, Seminars in radiation oncology.
[3] J. Wong,et al. Potential for dose escalation in the radiotherapy of hepatic tumors using active breathing control (ABC): A planning study , 1998 .
[4] L. Boersma,et al. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] C. Coleman,et al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Flavio Crippa,et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Wong,et al. The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.
[8] Vijayakumar,et al. Radiation Therapy Techniques in the Treatment of Hodgkin's Disease. , 1996, Seminars in radiation oncology.
[9] A. Hagenbeek,et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. , 1995, Journal of the National Cancer Institute.
[10] J M Balter,et al. Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors. , 1997, International journal of radiation oncology, biology, physics.
[11] E. Winer,et al. Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. , 1990, International journal of radiation oncology, biology, physics.
[12] S. Shapiro,et al. Prospective study of long-term pulmonary manifestations of mantle irradiation. , 1990, International journal of radiation oncology, biology, physics.
[13] R. Weichselbaum,et al. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] S. Donaldson,et al. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. , 1989, International journal of radiation oncology, biology, physics.
[15] E. Block,et al. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. , 1989, International journal of radiation oncology, biology, physics.
[16] S L Hancock,et al. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.
[17] J Wong,et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. , 1997, International journal of radiation oncology, biology, physics.
[18] J. Cosset,et al. Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience , 1991 .
[19] M. Henry-Amar,et al. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. , 1990, Seminars in oncology.
[20] E. Noordijk,et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. , 1990, International journal of radiation oncology, biology, physics.
[21] G J Kutcher,et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.
[22] S. Rosenberg,et al. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. , 1982, Blood.
[23] M. Martel,et al. Dose-volume analysis of excess cardiac irradiation associated with splenic treatment in Hodgkin's disease , 1998 .
[24] R. Olshen,et al. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] T. Landberg,et al. Original article: Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin's disease , 1992 .
[26] B. Clarkson,et al. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] M. Tubiana,et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. , 1991, International journal of radiation oncology, biology, physics.
[28] S. Hancock,et al. Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. , 1988, Annals of internal medicine.
[29] M Goitein,et al. The effect of the respiratory cycle on mediastinal and lung dimensions in Hodgkin's disease. Implications for radiotherapy gated to respiration , 1987, Cancer.
[30] L. Kalish,et al. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. , 1995, The cancer journal from Scientific American.